Compare IT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | TECH |
|---|---|---|
| Founded | 1979 | 1976 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 8.6B |
| IPO Year | 2010 | 1995 |
| Metric | IT | TECH |
|---|---|---|
| Price | $162.88 | $51.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $189.25 | $71.82 |
| AVG Volume (30 Days) | 1.5M | ★ 3.3M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.18 | 0.81 |
| Revenue | ★ $2,021,441,000.00 | $1,219,635,000.00 |
| Revenue This Year | $3.52 | $2.49 |
| Revenue Next Year | $5.08 | $6.40 |
| P/E Ratio | ★ $50.60 | $62.72 |
| Revenue Growth | ★ 13.30 | 5.23 |
| 52 Week Low | $139.18 | $43.20 |
| 52 Week High | $434.12 | $72.16 |
| Indicator | IT | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 61.15 | 54.48 |
| Support Level | $142.37 | $49.98 |
| Resistance Level | $172.23 | $57.86 |
| Average True Range (ATR) | 7.01 | 2.10 |
| MACD | 1.50 | 0.74 |
| Stochastic Oscillator | 92.92 | 92.39 |
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.